Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice
Aging Cell · 2025-01 · 24 (1)
DOI: 10.1111/acel.14368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 16.10.2024. Verfasst von Wanhong Han und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Labora…. Hauptthemen laut MEDLINE: Alzheimer Disease, Citric Acid Cycle, 3-Hydroxybutyric Acid. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Clinical Research Center for Brain Diseases, Project of Xiamen Cell Therapy Research, Xiamen Clinical Research Center for Neurological Diseases.
Themen: Demenz
Abstract (Originalsprache)
Lysine β‐hydroxybutyrylation (Kbhb) is a post‐translational modification that has recently been found to regulate protein functions. However, whether and how protein Kbhb modification participates in Alzheimer's disease (AD) remains unknown. Herein, we carried out 4D label‐free β‐hydroxybutylation quantitative proteomics using brain samples of 8‐month‐old and 2‐month‐old APP/PS1 AD model mice and wild‐type (WT) controls. We identified a series of tricarboxylic acid (TCA) cycle‐associated enzymes including citrate synthase (CS) and succinate‐CoA ligase subunit alpha (SUCLG1), whose Kbhb modifications were decreased in APP/PS1 mice at pathological stages. Sodium β‐hydroxybutyrate (Na‐β‐OHB) treatment markedly increased Kbhb modifications of CS and SUCLG1 and their enzymatic activities, leading to elevated ATP production. We further found that Kbhb modifications at lysine 393 site in CS and at lysine 81 site in SUCLG1 were crucial for their enzymatic activities. Finally, we found that β‐OHB levels were decreased in the brain of APP/PS1 mice at pathological stages. While ketogenic diet not only significantly increased β‐OHB levels, Kbhb modifications and enzymatic activities of CS and SUCLG1, and ATP production, but also dramatically attenuated β‐amyloid plaque pathologies and microgliosis in APP/PS1 mice. Together, our findings indicate the importance of protein Kbhb modification for maintaining normal TCA cycle and ATP production and provide a novel molecular mechanism underlying the beneficial effects of ketogenic diet on energy metabolism and AD intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Laboratory of Brain Center, the First Affiliated Hospital of Xiamen Universi…
- Xiamen Key Laboratory of Brain Center, the First Affiliated Hospital of Xiamen University, and Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medic…
- Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
- Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
ORCID-Profile: Yun-Wu Zhang, Zhanxiang Wang
Förderung
- Fujian Provincial Clinical Research Center for Brain Diseases
- Project of Xiamen Cell Therapy Research
- Xiamen Clinical Research Center for Neurological Diseases
- 2020 Joint Support of Key Projects on Health Care
- National Natural Science Foundation of China
Zitieren
APA
Han, W., Zhang, B., Zhao, W., Zhao, W., He, J., Qiu, X., Zhang, L., Wang, X., Wang, Y., Lu, H., Zhang, Y., Xie, Y., Geng, Y., Zhao, W., Huang, Q., Zhang, Y. W., & Wang, Z. (2025). Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice. Aging Cell, 24(1). https://doi.org/10.1111/acel.14368
Vancouver
Han W, Zhang B, Zhao W, Zhao W, He J, Qiu X, et al. Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice. Aging Cell. 2025;24(1). doi:10.1111/acel.14368
BibTeX
@article{Han2025,
author = {Han, Wanhong and Zhang, Bingchang and Zhao, Wenpeng and Zhao, Wentao and He, Jiawei and Qiu, Xiansheng and Zhang, Liang and Wang, Xiuyan and Wang, Yong and Lu, Hanwen and Zhang, Yaya and Xie, Yuanyuan and Geng, Yanyan and Zhao, Wujie and Huang, Qionghui and Zhang, Yun-Wu and Wang, Zhanxiang},
title = {Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice},
journal = {Aging Cell},
year = {2025},
volume = {24},
number = {1},
doi = {10.1111/acel.14368}
}
EUVIMED